Lexiva (fosamprenavir) approved.
The FDA approved a prodrug that becomes amprenavir in the body, but has practical advantages over amprenavir.
D002219:Carbamates; D017277:Drug Approval; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D013449:Sulfonamides; D014481:United States; D014486:United States Food and Drug Administration
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D013449:Sulfonamides; C426859:fosamprenavir